HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshimasa Tanaka Selected Research

Hemorrhage

10/2012Characteristics of hemorrhagic peptic ulcers in patients receiving antithrombotic/nonsteroidal antiinflammatory drug therapy.
7/2012Predictive factors for colonic diverticular rebleeding: a retrospective analysis of the clinical and colonoscopic features of 111 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshimasa Tanaka Research Topics

Disease

57Neoplasms (Cancer)
09/2023 - 09/2002
8Breast Neoplasms (Breast Cancer)
01/2021 - 12/2009
5Infections
10/2020 - 07/2005
5Carcinoma (Carcinomatosis)
12/2019 - 09/2008
5Renal Cell Carcinoma (Grawitz Tumor)
09/2013 - 04/2007
4Autoimmune Diseases (Autoimmune Disease)
06/2022 - 01/2012
4Neoplasm Metastasis (Metastasis)
03/2022 - 02/2010
3Carcinogenesis
03/2024 - 09/2002
3Gastroesophageal Reflux (GERD)
01/2021 - 02/2017
2Esophageal Achalasia (Megaesophagus)
03/2024 - 03/2018
2Fibrosis (Cirrhosis)
08/2023 - 01/2020
2Prostatic Neoplasms (Prostate Cancer)
06/2022 - 01/2022
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021 - 02/2021
2Lung Neoplasms (Lung Cancer)
01/2020 - 01/2018
2Multiple Myeloma
01/2017 - 04/2013
2Melanoma (Melanoma, Malignant)
01/2016 - 09/2013
2Myeloid Leukemia (Leukemia, Myelocytic)
01/2014 - 05/2013
2Ovarian Neoplasms (Ovarian Cancer)
09/2013 - 02/2007
2Lymphoma (Lymphomas)
05/2013 - 02/2003
2Hemorrhage
10/2012 - 07/2012
1Mucormycosis
03/2024
1Drug-Related Side Effects and Adverse Reactions
03/2024
1Aspergillosis
03/2024
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2024
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2023
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2023
1Hypohidrosis
07/2023
1Cryptococcosis
01/2023
1Triple Negative Breast Neoplasms
01/2023
1Mesothelioma
01/2023
1Nasopharyngeal Carcinoma
01/2023
1Bronchiectasis
12/2022
1Situs Inversus
12/2022
1Sinusitis
12/2022
1Familial Mediterranean Fever (Periodic Disease)
06/2022
1Deglutition Disorders (Dysphagia)
01/2022
1Leukemia
01/2022
1Disease Progression
01/2022
1Dyspepsia (Indigestion)
01/2022

Drug/Important Bio-Agent (IBA)

12Zoledronic Acid (Zometa)FDA Link
01/2019 - 12/2009
10Diphosphonates (Bisphosphonates)IBA
03/2021 - 04/2003
9Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2003
6Monoclonal AntibodiesIBA
06/2022 - 09/2008
6NitrogenIBA
03/2021 - 04/2003
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020 - 09/2002
5CytokinesIBA
03/2024 - 09/2008
5AntigensIBA
06/2023 - 03/2006
5ProdrugsIBA
03/2021 - 12/2016
5Immune Checkpoint InhibitorsIBA
01/2021 - 01/2016
5LigandsIBA
09/2013 - 02/2007
4Interleukin-18 (Interleukin 18)IBA
01/2023 - 04/2013
4Interleukin-2 (IL2)IBA
01/2023 - 02/2010
3CollagenIBA
08/2023 - 01/2020
3Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2014
3Terpenes (Terpenoids)IBA
01/2021 - 11/2011
3DNA (Deoxyribonucleic Acid)IBA
11/2020 - 03/2006
3InterferonsIBA
01/2020 - 01/2017
2Antifungal AgentsIBA
03/2024 - 10/2020
2Caspase 3 (Caspase-3)IBA
01/2023 - 01/2021
2Neoplasm Antigens (Tumor Antigens)IBA
01/2023 - 01/2018
2Biomarkers (Surrogate Marker)IBA
12/2022 - 12/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 03/2018
2AcidsIBA
01/2021 - 01/2017
2diphosphoric acid (pyrophosphoric acid)IBA
01/2021 - 01/2017
2Pamidronate (Aredia)FDA LinkGeneric
01/2021 - 04/2003
2prenylIBA
01/2021 - 01/2017
2Letrozole (Femara)FDA LinkGeneric
04/2018 - 11/2014
2Estrogen ReceptorsIBA
04/2018 - 11/2014
2EnzymesIBA
03/2018 - 04/2007
2Immunoglobulin G (IgG)IBA
02/2012 - 03/2010
1Myosin-Light-Chain PhosphataseIBA
03/2024
1Interleukin-22 (IL-22)IBA
03/2024
1Interleukin-4 (Interleukin 4)IBA
03/2024
1Interleukin-17 (Interleukin 17)IBA
03/2024
1Myosin Light Chains (Myosin Essential Light Chain)IBA
03/2024
1Conditioned Culture MediaIBA
03/2024
1Peptides (Polypeptides)IBA
09/2023
1Myelin Proteolipid ProteinIBA
09/2023
1Collagen Type I (Type I Collagen)IBA
08/2023
1Odorant Receptors (Odorant Receptor)IBA
07/2023
1ButyrophilinsIBA
01/2023
11H-tetrazole (tetrazole)IBA
01/2023
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2023
1Fibronectins (Fibronectin)IBA
01/2023
1MacrolidesIBA
12/2022
1Single-Domain AntibodiesIBA
06/2022
1Z 338IBA
01/2022
1Antifibrotic AgentsIBA
01/2022
1compound 17IBA
01/2022
1Interleukin-23 (Interleukin 23)IBA
11/2021
1InterleukinsIBA
11/2021
1Ustekinumab (CNTO 1275)FDA Link
11/2021

Therapy/Procedure

27Immunotherapy
01/2024 - 09/2002
19Therapeutics
06/2023 - 12/2009
3Cell- and Tissue-Based Therapy (Cell Therapy)
10/2023 - 01/2019
2Castration
06/2022 - 01/2022
2Transplantation
09/2013 - 01/2012
2Drug Therapy (Chemotherapy)
04/2013 - 10/2012
2Nephrectomy
08/2011 - 02/2010
1Myotomy
03/2024